Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.

Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.

Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.

The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.

DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral researchers can ...

A small conference with big ambitions mirrors the rapid growth of Chinese biotech, invites comparisons to U.S. biotech ...

Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.

The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in doctor offices. It applies to ...

In 2013, the House Republican, who had become the party’s de facto “chief political strategist,” was at a Virginia resort with his colleagues, working to shift the GOP away from its stereotype as a ...

Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.

The Department of Health and Human Services announced a set of new initiatives aimed at speeding up clinical trials by ...

Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing ...